Lupin Announces the Approval of Dapagliflozin Tablets in the United States

B MUMBAI, India and NAPLES, Fla., April 7, 2026 /PRNewswire/ — Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN)…
posteditor
posteditor
Articles: 16137

Other News